Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MFF pseudogene 2 (MFFP2) is a retrotransposed, processed pseudogene of the mitochondrial fission factor (MFF) gene in humans, mapped to chromosome 7[3][11]. It does not code for a functional protein product. Like most processed pseudogenes, MFFP2 contains exonic sequences similar to its parent gene but lacks introns and often critical regulatory/protein-coding elements, typically rendering it transcriptionally silent or non-functional[3][9][11]. There is no evidence that MFFP2 acts as a therapeutic target, nor are there reports of its involvement in disease or cellular processes. Cataloged as HGNC:54540, it is considered a non-coding genomic element[10][11]. The functional, protein-coding gene MFF (mitochondrial fission factor) is responsible for mitochondrial and peroxisomal fission[1][4], but MFFP2 is not known to have any corresponding activity or relevance in cell biology or medicine. MFF pseudogene 2 is not a therapeutic target, is not known to be functional, and is cataloged as a processed pseudogene. No disease involvement, molecular activity, or aliases beyond its systematic name are reported.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MFF pseudogene 2 (MFFP2).